GripAble, a London-based digital healthcare start-up delivering rehabilitation programmes to people with neurological and musculoskeletal conditions, today announced the successful close of an $11m Series A funding round. The new funding, led by IP Read More
Tags :Parkwalk Advisors
OW Smell Digital – the digital smell company launches with £1m seed funding Founded by two leading scientists, Emanuela Maggioni and Marianna Obrist, with lead investment from Parkwalk Advisors London, 15th March 2022 – A spinout from the Read More
Paragraf raises $60m as graphene-based electronics company sets sights on international growth The funding round, which includes current investors Parkwalk and Amadeus, will enable the business to increase its technological capacity globally and enhance its Read More
BGF and Parkwalk lead £8.5m investment in Pathfinder Medical London, UK, 19 January 2022: Pathfinder Medical – a medical device company improving outcomes for vascular procedures – has secured an £8.5 million funding round led by investors BGF and Parkwalk, Read More
OXFORD, UK, 16th December, 2021 – Brainomix, the AI-powered medtech solutions company, today announces that it has closed a series B financing round, raising £16M ($21.2M) to fund its expansion into new markets and new therapeutic indications, Read More
Entia, a medical technology business, which recently announced a commercial partnership with Pfizer UK, raised $12 million earlier in the year in a funding round led by UK growth capital investor BGF, with participation from existing Read More
Growthdeck-led fundraise for digital archivers Arkivum closes at over £1.5m Arkivum is partnering with Google to deliver a €4.8m data archiving project Private equity investment firm Growthdeck – alongside existing investors, IP Group and Parkwalk – Read More
Mogrify completes Series A financing totaling $33 million USD Second close of $17 million USD brings total raised in Series A to $33 million USD Funding led by Parkwalk Advisors with participation from Read More
HexagonFab secures £1.9m seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides convenient and affordable access to molecular binding analytics Cambridge, April 20, 2021 – University Read More
Oxford Endovascular Ltd raises $10m to develop an origami engineered medical device to prevent brain haemorrhage Funding will support the company to achieve first in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British Read More